ALK and lung carcinoma: This interaction amplifies lung cancer growth through the upregulation of oncogenic factors like MMP9 and anaplastic lymphoma kinase (ALK), and the downregulation of tumour suppressor genes such as kruppel‐like factor 6 (KLF6).